Return to: Medical School : Academic Health Center : myAHC : U of M Home

Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
IPTR masthead graphic
Whats Inside
Contact Us

About Us

Registry Staff

Annual Reports

IPTR Database

IPTR Links

Slide Library

 

IPTR Home

Home > Annual Reports > 2003 Annual Report > Effect of Recipient Age on USA Primary Pancreas Transplant Outcome by Era

Printer-friendly version   Mail this page to a friend

Effect of Recipient Age on USA Primary Pancreas Transplant Outcome by Era


Pancreas transplant outcome has improved over time in recipients >45 years of age and the proportion of these recipients has increased from 9% in 1987-92 to 29% in 2001-03 (p=0.0001). Outcomes by years are grouped into eras (Figure 13a). Primary DD 1-year patient survival by recipient age is illustrated in Figures 13b (>45) and 13c (<45); primary pancreas graft survival by recipient age in Figures 13d and 13e.

Patient and Graft Survival Eras by Recipient Age
Figure 13a

1-Year Patient Survival Age > 45
Figure 13b

1-Year Patient Survival Age ≤ 45
Figure 13c

For SPK recipients, 1-year patient survival improved from 87% in the 1987-92 era to 93% in the 2001-03 era (p<0.003) and pancreas graft survival improved from 75% in the 1987-92 era to 85% in the 2001-03 era (p=0.002). Kidney GSRs were 81% and 90% respectively (p<0.0005). In the 2001-03 era, patient survival and pancreas graft survival were nearly equal in recipients >45 years and younger recipients: a difference of only 2% and 1% respectively.

In the solitary groups, there were few recipients >45 in the early eras.  In the PAK group, 1-year patient survival changed from 73% in the 1987-92 era to 93% in the 2001-03 era (p=0.07). PAK pancreas 1-year graft survival dramatically improved from 42% in the 1987-92 era to 76% in the 2001-03 era (p=0.02). Again, in the 2001-03 era PAK older and younger recipients had nearly equal survival rates for patient and pancreas graft: a difference of 2% and 1% respectively.  For PTA, 1-year patient survival has always been at least 80%; for the 2001-03 era it was 98%.  PTA 1-year graft survival has markedly improved from 56% in the 1987-92 era to 75% in the 2000-03 era (p=<0.002).  As with SPK and PAK, in the 2001-03 era PTA patient and pancreas graft survival rates for age >45 years were nearly equivalent to younger recipients: a difference of only 1% for each.

1-Year Pancreas Graft Function Age > 45
Figure 13d

1-Year Pancreas Graft Function Age ≤ 45
Figure 13e

Previous page / Next page / Index


Feedback | Notice of Privacy Practices

 
The University of Minnesota is an equal opportunity educator and employer.